Cargando…
Infections during Non-Neutropenic Episodes in Pediatric Cancer Patients—Results from a Prospective Study in Two Major Large European Cancer Centers
Whereas the clinical approach in pediatric cancer patients with febrile neutropenia is well established, data on non-neutropenic infectious episodes are limited. We therefore prospectively collected over a period of 4 years of data on all infectious complications in children treated for acute lympho...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9311840/ https://www.ncbi.nlm.nih.gov/pubmed/35884154 http://dx.doi.org/10.3390/antibiotics11070900 |
_version_ | 1784753692355854336 |
---|---|
author | Schöning, Stefan Barnbrock, Anke Bochennek, Konrad Gordon, Kathrin Groll, Andreas H. Lehrnbecher, Thomas |
author_facet | Schöning, Stefan Barnbrock, Anke Bochennek, Konrad Gordon, Kathrin Groll, Andreas H. Lehrnbecher, Thomas |
author_sort | Schöning, Stefan |
collection | PubMed |
description | Whereas the clinical approach in pediatric cancer patients with febrile neutropenia is well established, data on non-neutropenic infectious episodes are limited. We therefore prospectively collected over a period of 4 years of data on all infectious complications in children treated for acute lymphoblastic or myeloid leukemia (ALL or AML) and non-Hodgkin lymphoma (NHL) at two major pediatric cancer centers. Infections were categorized as fever of unknown origin (FUO), and microbiologically or clinically documented infections. A total of 210 patients (median age 6 years; 142 ALL, 23 AML, 38 NHL, 7 leukemia relapse) experienced a total of 776 infectious episodes (571 during neutropenia, 205 without neutropenia). The distribution of FUO, microbiologically and clinically documented infections, did not significantly differ between neutropenic and non-neutropenic episodes. In contrast to neutropenic patients, corticosteroids did not have an impact on the infectious risk in non-neutropenic children. All but one bloodstream infection in non-neutropenic patients were due to Gram-positive pathogens. Three patients died in the context of non-neutropenic infectious episodes (mortality 1.4%). Our results well help to inform clinical practice guidelines in pediatric non-neutropenic cancer patients presenting with fever, in their attempt to safely restrict broad-spectrum antibiotics and improve the quality of life by decreasing hospitalization. |
format | Online Article Text |
id | pubmed-9311840 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-93118402022-07-26 Infections during Non-Neutropenic Episodes in Pediatric Cancer Patients—Results from a Prospective Study in Two Major Large European Cancer Centers Schöning, Stefan Barnbrock, Anke Bochennek, Konrad Gordon, Kathrin Groll, Andreas H. Lehrnbecher, Thomas Antibiotics (Basel) Article Whereas the clinical approach in pediatric cancer patients with febrile neutropenia is well established, data on non-neutropenic infectious episodes are limited. We therefore prospectively collected over a period of 4 years of data on all infectious complications in children treated for acute lymphoblastic or myeloid leukemia (ALL or AML) and non-Hodgkin lymphoma (NHL) at two major pediatric cancer centers. Infections were categorized as fever of unknown origin (FUO), and microbiologically or clinically documented infections. A total of 210 patients (median age 6 years; 142 ALL, 23 AML, 38 NHL, 7 leukemia relapse) experienced a total of 776 infectious episodes (571 during neutropenia, 205 without neutropenia). The distribution of FUO, microbiologically and clinically documented infections, did not significantly differ between neutropenic and non-neutropenic episodes. In contrast to neutropenic patients, corticosteroids did not have an impact on the infectious risk in non-neutropenic children. All but one bloodstream infection in non-neutropenic patients were due to Gram-positive pathogens. Three patients died in the context of non-neutropenic infectious episodes (mortality 1.4%). Our results well help to inform clinical practice guidelines in pediatric non-neutropenic cancer patients presenting with fever, in their attempt to safely restrict broad-spectrum antibiotics and improve the quality of life by decreasing hospitalization. MDPI 2022-07-05 /pmc/articles/PMC9311840/ /pubmed/35884154 http://dx.doi.org/10.3390/antibiotics11070900 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Schöning, Stefan Barnbrock, Anke Bochennek, Konrad Gordon, Kathrin Groll, Andreas H. Lehrnbecher, Thomas Infections during Non-Neutropenic Episodes in Pediatric Cancer Patients—Results from a Prospective Study in Two Major Large European Cancer Centers |
title | Infections during Non-Neutropenic Episodes in Pediatric Cancer Patients—Results from a Prospective Study in Two Major Large European Cancer Centers |
title_full | Infections during Non-Neutropenic Episodes in Pediatric Cancer Patients—Results from a Prospective Study in Two Major Large European Cancer Centers |
title_fullStr | Infections during Non-Neutropenic Episodes in Pediatric Cancer Patients—Results from a Prospective Study in Two Major Large European Cancer Centers |
title_full_unstemmed | Infections during Non-Neutropenic Episodes in Pediatric Cancer Patients—Results from a Prospective Study in Two Major Large European Cancer Centers |
title_short | Infections during Non-Neutropenic Episodes in Pediatric Cancer Patients—Results from a Prospective Study in Two Major Large European Cancer Centers |
title_sort | infections during non-neutropenic episodes in pediatric cancer patients—results from a prospective study in two major large european cancer centers |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9311840/ https://www.ncbi.nlm.nih.gov/pubmed/35884154 http://dx.doi.org/10.3390/antibiotics11070900 |
work_keys_str_mv | AT schoningstefan infectionsduringnonneutropenicepisodesinpediatriccancerpatientsresultsfromaprospectivestudyintwomajorlargeeuropeancancercenters AT barnbrockanke infectionsduringnonneutropenicepisodesinpediatriccancerpatientsresultsfromaprospectivestudyintwomajorlargeeuropeancancercenters AT bochennekkonrad infectionsduringnonneutropenicepisodesinpediatriccancerpatientsresultsfromaprospectivestudyintwomajorlargeeuropeancancercenters AT gordonkathrin infectionsduringnonneutropenicepisodesinpediatriccancerpatientsresultsfromaprospectivestudyintwomajorlargeeuropeancancercenters AT grollandreash infectionsduringnonneutropenicepisodesinpediatriccancerpatientsresultsfromaprospectivestudyintwomajorlargeeuropeancancercenters AT lehrnbecherthomas infectionsduringnonneutropenicepisodesinpediatriccancerpatientsresultsfromaprospectivestudyintwomajorlargeeuropeancancercenters |